High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?

Leuk Lymphoma. 2008 Jan;49(1):4-5. doi: 10.1080/10428190701760078.
No abstract available

Publication types

  • Comment

MeSH terms

  • Amyloidosis / mortality
  • Amyloidosis / therapy*
  • Antineoplastic Agents / therapeutic use
  • Hematopoietic Stem Cell Transplantation / methods*
  • Hematopoietic Stem Cell Transplantation / mortality
  • Humans
  • Immunoglobulin Light Chains
  • Patient Selection
  • Survival Rate
  • Transplantation, Autologous

Substances

  • Antineoplastic Agents
  • Immunoglobulin Light Chains